Physician profile
James B Weidner
NPI 1396892162
$3,384.80
in general payments reported to CMS, 2019-2025
20 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $352 · 2021: $1,042 · 2022: $981 · 2024: $119 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,014.13 | 2020-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $463.96 | 2019-2022 | |
| Philips North America LLC | $400.88 | 2019-2021 | |
| Amarin Pharma, INC. | $133.92 | 2019 | |
| Pfizer INC. | $124.99 | 2019 | |
| Sk Life Science, INC. | $124.99 | 2022 | |
| Abbvie INC. | $124.99 | 2021 | |
| Genzyme Corporation | $124.83 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $124.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.69 | 2021 | |
| Glaxosmithkline, LLC. | $121.15 | 2022 | |
| Novartis Pharmaceuticals Corporation | $118.93 | 2019 | |
| Medtronic, INC. | $114.88 | 2022 | |
| Janssen Pharmaceuticals, INC | $85.49 | 2020 | |
| Merck Sharp & Dohme LLC | $68.01 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $48.09 | 2022 | |
| Boston Scientific Corporation | $25.09 | 2020 | |
| Medtronic Vascular, INC. | $17.52 | 2020 | |
| Abbott Laboratories | $15.15 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.40 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Weidner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.